Whitebox Advisors’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-46,000
Closed -$15.6K 370
2024
Q1
$15.6K Hold
46,000
﹤0.01% 198
2023
Q4
$10.6K Hold
46,000
﹤0.01% 168
2023
Q3
$7.59K Hold
46,000
﹤0.01% 217
2023
Q2
$7.09K Hold
46,000
﹤0.01% 264
2023
Q1
$4.5K Hold
46,000
﹤0.01% 435
2022
Q4
$2.76K Hold
46,000
﹤0.01% 601
2022
Q3
$3K Hold
46,000
﹤0.01% 806
2022
Q2
$13K Hold
46,000
﹤0.01% 627
2022
Q1
$18K Sell
46,000
-4,000
-8% -$1.82K ﹤0.01% 719
2021
Q4
$33K Buy
+50,000
New +$33.5K ﹤0.01% 665

Other funds holding AONCW

Whitebox Advisors's AONCW Position: Q2 2024 in Review

Whitebox Advisors sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 46,000 shares — an estimated $15.6K sold.

Whitebox Advisors first reported a position in AONCW in Q4 2021 and held it in 10 quarters. The position peaked at $33K in Q4 2021. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

  • Whitebox Advisors reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
  • Whitebox Advisors sold 46,000 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $15.6K.
  • Whitebox Advisors first reported a position in American Oncology Network, Inc. Warrant in Q4 2021 and held it in 10 quarters.
  • Whitebox Advisors's American Oncology Network, Inc. Warrant position peaked at $33K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on Whitebox Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.